Friday, April 10, 2015

Tekmira will resume safety study of Ebola drug within weeks

Canadian drugmaker Tekmira Pharmaceuticals said Friday it will restart a study of an experimental Ebola treatment in the coming weeks.

No comments:

Post a Comment